Title:
AGENT FOR AMELIORATION OF OPHTHALMIC CIRCULATORY DISORDER
Document Type and Number:
WIPO Patent Application WO/2008/023784
Kind Code:
A1
Abstract:
Disclosed is an agent for ameliorating an ophthalmic circulatory disorder for orally administering limaprost to a patient with the ophthalmic circulatory disorder in an amount of 5 to 50 μg per day for a period of 2 to 72 weeks. The agent can be administered orally to ameliorate the ophthalmic circulatory disorder, and treat a symptom induced by the ophthalmic circulatory disorder and/or prevent the progress of the symptom. Further, the agent can shorten the period required for disappearance of the hemorrhage of the optic fundus associated with the ophthalmic circulatory disorder and also shorten the period required for the recovery of decreased visual acuity and/or the amelioration of a visual field disorder.
More Like This:
Inventors:
AYAKI, Masahiko (1-30 fujigaoka Aoba-ku, Yokohama-sh, Kanagawa 01, 2278501, JP)
Application Number:
JP2007/066430
Publication Date:
February 28, 2008
Filing Date:
August 24, 2007
Export Citation:
Assignee:
Showa University (1-5-8 Hatanodai, Shinagawa-ku Tokyo, 55, 1428555, JP)
学校法人 昭和大学 (〒55 東京都品川区旗の台１丁目５番８号 Tokyo, 1428555, JP)
ONO PHARMACEUTICAL CO., LTD. (1-5 Doshomachi 2-chome, Chuo-ku Osaka-sh, Osaka 26, 5418526, JP)
学校法人 昭和大学 (〒55 東京都品川区旗の台１丁目５番８号 Tokyo, 1428555, JP)
ONO PHARMACEUTICAL CO., LTD. (1-5 Doshomachi 2-chome, Chuo-ku Osaka-sh, Osaka 26, 5418526, JP)
International Classes:
A61K31/5575; A61K9/16; A61K9/20; A61K9/48; A61K45/00; A61K47/04; A61K47/36; A61P9/00; A61P9/10; A61P27/02; A61K31/557; A61K9/16; A61K9/20; A61K9/48; A61K45/00; A61K47/02; A61K47/36; A61P9/00; A61P27/00
Attorney, Agent or Firm:
OHIE, Kunihisa et al. (OHIE Patent Office, Selva-Ningyocho 6F14-6, Nihonbashi-Ningyocho 2-chom, Chuo-ku Tokyo 13, 1030013, JP)
Download PDF: